longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Collegium Pharma

COLL

22.7500.74% ( -0.170 )
Closed: Sep 11, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 15.46, within the reasonable range, cheaper than 59.64% of the time in the past 3 years, and the industry ranks 26/258, the industry Median -1.28.

15.46xP/E
$22.75Stock price
$1.47Earnings per share
15.46xP/E
Stock price$22.75Earnings per share$1.47

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
18.42x
Typical range
11.86x–26.30x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0285684112

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
NVOUSNovo Nordisk AS
10.53x7.75%$190.49B
BMYUSBristol Myers Squibb
14.01x62.25%$130.00B
GSKUSGSK
15.22x6.56%$98.08B
UCBJYUSUCB S.A.
17.87x--$45.51B
HLNUSHaleon
18.66x2.92%$40.48B
OTSKYUSOtsuka Pharmaceutical
15.01x--$38.87B
DSNKYUSDaiichi Sankyo
19.61x--$32.93B
ZTSUSZoetis
11.43x6.81%$30.15B
ALPMYUSAstellas Pharma
11.20x--$26.11B
JAZZUSJazz Pharma
16.96x349.11%$15.96B
OPHLYUSOno Pharmaceutical
14.47x--$7.05B
INDVUSIndivior Pharmaceuticals
11.43x126.83%$4.07B
SNPHYUSSanten Pharmaceutical
14.65x--$3.62B
OGNUSOrganon
17.14x211.11%$3.58B
HRMYUSHarmony Biosciences
13.34x45.48%$2.42B
PBHUSPrestige Brands
12.93x7.48%$2.22B
GTBIFUSGreen Thumb Industries Inc.
13.25x--$1.68B
ANIPUSANI Pharma
15.83x49.55%$1.58B
PAHCUSPhibro Animal Health
14.50x26.75%$1.45B
OMERUSOmeros
10.60x1,880.00%$1.32B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.